[ad_1]
Image posted, fake images
Speculation about who will hold the top ministerial portfolios in the administration of US President-elect Joe Biden and the decisions he may make have caught the attention of British newspapers, as some of them dealt with possible options for Biden to lead the Pentagon, while the Corona virus continued to gain significant news space with the number of infections rising dramatically in Britain. again.
Biden maybe Choose aWoman to run the Pentagon
The Independent reported that US President-elect Joe Biden is expected to “take a historic step and elect a woman to head the Pentagon for the first time, breaking one of the few remaining obstacles for women” in politics. American.
He cited US officials and people with political knowledge that Michael Flournoy, a veteran Pentagon official and politically moderate, is the strongest choice for this position.
Flournoy’s election comes on the heels of a tumultuous period at the Pentagon, in which five men held high-ranking positions under President Donald Trump.
Mark Esper, the last defense secretary to leave office, was after Trump fired him on Monday for his rejection of some issues, including the withdrawal of US forces from some regions of the world and the use of the military to quell civil unrest in America.
If she is officially appointed, she will face Flournoy, according to the newspaper, in the future, “which is expected to include a reduction in Pentagon budgets and possible military involvement in the distribution of the Corona virus vaccine.”
The Independent noted that Democrats have long sought to nominate a woman for the top job in a division that didn’t open up all combat jobs for serving women until about five years ago.
Flournoy was “Hillary Clinton’s expected choice if she wins the 2016 election.” Her name first appeared as Biden’s first cabinet candidate, according to officials who spoke to The Independent on condition of anonymity.
Given her preference for “strong military cooperation overseas,” Flournoy, 59, worked several times at the Pentagon, beginning in the 1990s and most recently as Under Secretary for Policy in the Department of Defense from 2009 to 2012. .
Flournoy works on the board of directors of Booz Allen Hamilton, a defense contractor, which could raise concerns among some lawmakers, according to the newspaper. But his moderate views are likely to “ensure broad bipartisan support in a situation that requires Senate approval.”
ExceptTwo weeksThe next two are “decisive” in a England
Image posted, Dominic Lipinski / PA Media
Molly Blackall of the “Observer” newspaper quoted a government scientific adviser as saying that the next two weeks will be “extremely critical” in ensuring an end to the coronavirus lockdown in England, as planned on December 2.
Professor Susan Michi, a member of the government’s COVID-19 Behavioral Sciences Team, a subgroup of the Emergencies Scientific Advisory Group, said the country is entering two “challenging” weeks.
He also said that the development of an effective vaccine should not put people behind with the spread of the Corona virus in England.
She said in an interview with the BBC: “I think the next two weeks will be very crucial. Partly because of the weather, I also think that the promise of a vaccine can make people feel like they can be complacent in taking precautions.”
Michi said a vaccine is unlikely to be distributed until the end of the year or early 2021, which means the vaccine will not make a difference in the current second wave.
He urged people not to trust the promise of a vaccine and to follow established advice, “saying that this” will make Christmas celebrations more bearable. “
“Everyone should put together their entire design, to resist any incentive to break the rules of spacing and home visits; and pay attention to keeping interior spaces ventilated and sanitizing surfaces and hands,” Michi said.
A joint drug that reduces Corona patient deaths
Image posted, AFP
The highest percentage of deaths occurs among those over 80 years of age.
The Mail on Sunday newspaper said a drug to treat arthritis had been discovered to reduce deaths among hospitalized Covid-19 patients, by a notable two-thirds.
The researchers say that “pills taken daily reduce deaths by 71 percent in patients with moderate or severe symptoms.”
The most important thing, according to the newspaper, is that this drug is “effective in its use to treat the elderly from Covid 19, which raises hopes of saving the most vulnerable groups.”
The drug, called baricitinib, and marketed under the brand name Olumiant, is a relatively new drug for rheumatoid arthritis and has only been available for three years.
But in February, he identified himself as a strong candidate to help treat COVID-19.
